Coinspeaker MRNA Stock Up 1.32% Now, Moderna Proceeds for Phase 2 Testing of Coronavirus VaccineModerna Inc proceeds ahead for the Phase 2 clinical trial of its vaccine to fight with the coronavirus. The company has received a nod from the Food and Drug Administration to proceed ahead with the project. MRNA stock is in the green in the pre-market.MRNA Stock Up 1.32% Now, Moderna Proceeds for Phase 2 Testing of Coronavirus Vaccine